Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.433 USD | +5.33% | -13.40% | +58.61% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.34M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.55
x | P/E ratio 2025 * |
-1.15
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.62% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | +5.33% | ||
1 week | -13.40% | ||
Current month | -11.02% | ||
1 month | -5.04% | ||
3 months | +31.21% | ||
6 months | +116.18% | ||
Current year | +58.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 0.433 | +5.33% | 655,348 |
24-06-07 | 0.4111 | -0.48% | 377,743 |
24-06-06 | 0.4131 | -5.36% | 614,560 |
24-06-05 | 0.4365 | -0.64% | 343,904 |
24-06-04 | 0.4393 | -12.14% | 681,239 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.61% | 28.1M | |
+49.41% | 57.87B | |
+41.65% | 40.25B | |
-6.72% | 39.94B | |
-5.96% | 28.54B | |
+12.99% | 26.4B | |
-19.82% | 19.33B | |
+32.35% | 12.4B | |
-0.08% | 12.23B | |
+25.18% | 12.2B |
- Stock Market
- Equities
- BCLI Stock